Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

Viral Infections, Non-HIV

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients

Emerg Infect Dis.

Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL

doi: 10.3201/eid2607.200841.

Viral Infections, Non-HIV

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Eur J Nucl Med Mol Imaging.

Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, Chen B, Zhang Z, Guan W, Ling Z, Jiang R, Hu T, Ding Y, Lin L, Gan Q, Luo L, Tang X, Liu J

doi: 10.1007/s00259-020-04735-9.

Viral Infections, Non-HIV

SARS-CoV-2-reactive interferon-γ-producing CD8⁺ T cells in patients hospitalized with Coronavirus Disease 2019

J Med Virol.

Giménez E, Albert E, Torres I, Remigia MJ, Alcaraz MJ, Galindo MJ, Blasco ML, Solano C, Forner MJ, Redón J, Signes-Costa J, Navarro D

doi: 10.1002/jmv.26213.

Viral Infections, Non-HIV

Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients

Clin Infect Dis.

Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, Guo L, Zhang G, Li H, Xu Y, Chen M, Gao Z, Wang J, Ren L, Li M

doi: 10.1093/cid/ciaa203.

Viral Infections, Non-HIV

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019

Clin Infect Dis.

Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ

doi: 10.1093/cid/ciaa851.

Viral Infections, Non-HIV

A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2)

Clin Infect Dis.

Bryson-Cahn C, Duchin J, Makarewicz VA, Kay M, Rietberg K, Napolitano N, Kamangu C, Dellit TH, Lynch JB

doi: 10.1093/cid/ciaa256.

Viral Infections, Non-HIV

Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV

doi: 10.1016/j.ijid.2020.03.071.

Viral Infections, Non-HIV

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Emerg Infect Dis.

Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, Wang L, Whitaker B, Lynch B, Gautam R, Schindewolf C, Lokugamage KG, Scharton D, Plante JA, Mirchandani D, Widen SG, Narayanan K, Makino S, Ksiazek TG, Plante KS, Weaver SC, Lindstrom S, Tong S, Menachery VD, Thornburg NJ

doi: 10.3201/eid2606.200516.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Related content

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019

Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019

A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2)

Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

SARS-CoV-2-reactive interferon-γ-producing CD8⁺ T cells in patients hospitalized with Coronavirus Disease 2019